Method for treating ophthalmic disorders with IGFBP

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530350, 530324, 435 691, A61K 3827, A61K 3828

Patent

active

061242594

ABSTRACT:
This is a method for treating ophthalmic disorders associated with an excess of IGF-I or IGF-II. The method comprises administering individuals with an IGF excess insulin-like growth factor binding protein (IGFBP). The preferred form is IGFBP-3.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 5187151 (1993-02-01), Clark et al.
patent: 5200509 (1993-04-01), Spencer et al.
patent: 5407913 (1995-04-01), Sommer et al.
Robert Baxter et al "Growth Hormone Dependent Insulin Like Growth Factor (IGF) Binding Protein From Human Plasma Differs From Other Human IGF Binding Proteins" Biochemical and Biophysical Research Communications, vol. 139, No. 3, pp. 1256-1261, 1986.
Wiedemann, "Growth Factor in Retinal Diseases: Proliferature Diabetic Retinopathy, and Retinal Degeneration" Survey of Ophthalmology, vol. 36, No. 5, pp. 375-384, 1992.
Shunichi Shimasaki et al., "Identification and Molecular Characterization of Insulin Like Growth Factor Binding Proteins (IGFBP-1, -2,-3,-4,-5 and 6)" Progress in Growth Factor Research, vol. 3, pp. 243-266, 1991.
Barritault et al. "Is There a Ubiquitous Growth Factor in the Eye? Proliferation Induced in Different Cell Types by Eye-Derived Growth Factors" Differentiation (1981) 18:29-42.
Baxter et al. "Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins" Biochem. Biophys. Res. Comm. (1986) 139(3):1256-1261.
Binkert et al., "Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)" EMBO Journal (1989) 8(9):2497-2502.
Blum et al. "Plasma IGFBP-3 levels as clinical indicators" Spencer, E.M., ed., Modern Concepts in Insulin-Like Growth Factors, Elsevier, New York, (1991) pp. 381-393.
Brewer et al. "Cloning, Characterization, and Expression of a Human Insulin-like Growth Factor Binding Protein" Biochem. Biophys. Res. Comm. (1988) 152(3):1289-1297.
Busby et al. "Purification of a 31,000-Dalton Insulin-like Growth Factor Binding Protein from Human Amniotic Fluid Isolation of Two Forms with Different Biologic Actions" J. Biol. Chem. (1988) 263(28):14203-14210.
Chen et al. "Angiogenic activity of vitreous and retinal extract" Assoc. Res. Ophthal. (1980) 19(6):596.
D'Amore et al. "Endothelial Cell Mitogens Derived from Retina and Hypothalamus: Biochemical and Biological Similarities" J. Cell. Biol. (1984) 99:1545-1549.
Deitz, M.D. et al. "Progressive Hyperopia in Radial Keratotomy" Ophthalmology (1986) 93(10):1284-1289.
Dills et al. "Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes" Diabetes (1991) 40:1725-1730.
Drop et al. "Immunoassay of a somatomedin-binding protein form human amniotic fluid: levels in fetal, neonatal, and adult sera" J. Clin. Endocrin. Met. (1984) 84:908-915.
Elgin et al. "An insulin-like growth factor (IGF) binding protein enhances the biologic response of IGF-I" Proc. Natl. Acad. Sci. USA (1987) 84:3254-3258.
Elstow et al. "Bovine Retinal Angiogenesis Factor Is a Small Molecule (Molecular Mass<600)" Invest. Ophthalmol. Vis. Sci. (1985) 26(1):74-79.
Feeney-Burns et al. "Aging Human RPE: Morphometric Analysis of Macular, Equatorial, and Peripheral Cells" Invest. Ophthalmol. Vis. Sci. (1984) 25(2):195-200.
Frank, R.N. "On the pathogenesis of diabetic retinopathy" Opthalmol. (1990) 98:586-593.
Fredj-Reygrobellet et al. "Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy" Opthalm. Res. (1991) 23:154-161.
Gass, M.D. "Idiopathic Senile Macular Hole, Its Early Stages and Pathogenesis" Arch. Ophthalmol. (1988) 106:629-639.
Glaser, M.D. et al. "The Demonstration of Angiogenic Activity from Ocular Tissues" Ophthalmology (1980) 87(5):440-446.
Grant et al. "Insulin-Like Growth Factors in Vitreous, Studies in Control and Diabetic Subjects with Neovascularization" Diabetes (1966) 35:416-420.
Grant et al."Insulin-like growth factor I stimulates proliferation, migration, and plasminogen activator release by human retinal pigment epithelial cells" Curr. Eye Res. (1990) 9:323-335.
Hjelmeland et al., "Growth factors: soluble mediators of wound repair and ocular fibrosis", March of Dimes Birth Defects Compendium, 2nd Ed., pp. 87-101.
Hyldahl, "Control of Cell Proliferation in the Human Embryonic Cornea: An Autoradiographic Analysis of the Effect of Growth Factors on DNA Synthesis in Endothelial and Stromal Cells in Organ Culture and After Explanation In Vitro" J. Cell. Sci. (1986) 83:1-21.
Karas et al. "Restenosis following coronary angioplasty" Clin. Cardiol. (1991) 14:791-801.
King et al. "Receptors and growth-promoting effects of insulin-like growth factors on cells from bovine retinal capillaries and aorta" J. Clin. Invest. (1985) 75:1028-1036.
Knauer et al. "Purification and characterization of multiplication-stimulating activity (MSA) carrier protein" J. Supramol. Struct. Cell. Biochem. (1981) 15:177-191.
Kuffer et al. "Partial purification of a specific inhibitor of the insulin-like growth factors by reversed-phase high-performance liquid chromatography" J. Chromophotog. (1984) 336:87-92.
Langer et al. "Biocompatibility of polymeric delivery systems for macromolecules" J. Biomed. Mater. Res. (1981) 15:267-277.
Langer et al. "Isolation of a Cartilage Factor That Inhibits Tumor Neovascularization" Science (1976) 193(4247):70-72.
Leschey et al. "Growth factor responsiveness of human retinal pigment epithelial cells" Invest. Ophthalmol. Vis. Sci. (1990) 31(5):839-846.
Maack et al. "Molecular genetics and actions of recombinant insulin-like growth binding protein-3" Spencer, E.M., ed., Modern Concepts in Insulin-Like Growth Factors, Elsevier, New York, (1991) pp. 715-728.
Martin et al. "Insulin-like Growth Factor-binding Protein from Human Plasma" J. Biol. Chem. (1986) 261(19):8754-8760.
McAvoy et al. "Growth factors in the eye" Prog. Growth Factor Res. (1990) 2:29-43.
Merimee et al. "Insulin-Like Growth Factors, Studies in Diabetics with and without Retinopathy" N. Engl. J. Med. (1983) 309(9):527-529.
Morse et al. "Bovine retinal pigment epithelium promotes proliferation of choroidal endothelium in vitro" Arch. Ophthalmol. (1989) 107:1659-1663.
Raymond et al. "Isolation and Identification of Stimulatory and Inhibitory Cell Growth Factors in Bovine Vitreous" Exp. Eye Res (1982) 34: 267-286.
Ruelius-Altemose et al. "Further Studies on Inhibition and Stimulation of Vascular Endothelial Cell Growth" Invest. Ophthalmol. Vis. Sci. (1985) (ARVO Suppl) 26(3):25.
Shimasaki et al. "Identification of Five Different Insulin-like Growth Factor Binding Proteins (IGFBPs) from Adult Rat Serum and Molecular Cloning of a Novel IGFBP-5 in Rat and Human" J. Biol. Chem. (1991) 266(16):10646-10653.
Shimasaki et al. "Isolation and Molecular Cloning of Insulin-Like Growth Factor-Binding Protein-6" Mol. Endocrinol. (1991) 5(7):938-948.
Shimasaki et al. "Molecular Cloning of the cDNAs Encloding a Novel Insulin-Like Growth Factor-Binding Protein from Rat and Human" Mol. Endocrinol. (1990) 4(10):1451-1458.
Sidman et al. "Controlled Realease of Macromolecules and Pharmaceuticals from Synthetic Polypeptides Based on glutamic Acid" Biopolymers (1983) 22(1):547-556.
Sommer et al. "Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3" International Symposium on Insulin-Like Growth Factors/Somatomedins, San Francisco, CA, Modern Concepts of Insulin-Like Growth Factors, (1991) E. M. Spencer, ed., Elsevier, New York, 715-728.
Waring et al. "Stability of refraction During Four Years After Radial Keratotomy in the Prospective Evaluation of Radial Keratotomy Study" Am. J. Ophthalmol. (1991) 111:133-144.
Weller et al. "Prolifertive vitreoretinopathy--is it anything more than wound healing at the wrong place?"Int. Ophthalmol. (1990) 14:105-117.
Wiedemann, P. "Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration" Surv. Opthalmol. (1992) 36:373-384.
Wood et al. "Cloning and Expression of the growth ho

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating ophthalmic disorders with IGFBP does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating ophthalmic disorders with IGFBP, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating ophthalmic disorders with IGFBP will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2100172

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.